Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of The Effect of Vascular Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension Before and After Receiving Oral Alagebrium or Placebo for 8 Weeks (STRETCH)

NCT00302250 is registered in ClinicalTrials.gov with Synvista Therapeutics, Inc as lead sponsor.

NCT NCT00302250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00302250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of The Effect of Vascular Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension Before and After Receiving Oral Alagebrium or Placebo for 8 Weeks (STRETCH)
Lead sponsor
Synvista Therapeutics, Inc
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
December 31, 2006
Enrollment
70
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease